Neudle.com: dopamine receptor agonist

Differential
(Click to cross reference)

acrochordon

acromegaly

activities of daily living

Addison's disease

advances in neurology

adverse drug reaction

alcohol, neurologic complications with

altered states of consciousness, driving with

anemia, iron deficiency

angiography, cerebral

ankle edema

anticholinergic drugs

anticholinergic drugs, side effects of

anticonvulsants

anxiety

aortic valve, lesion of

aphasia

aphasia, rehabilitation

apomorphine

arrhythmia, cardiac

arterial dissection, aorta, cerebral symptoms with

arteriopathy

aspirin

ataxia, truncal

attention deficit disorder with hyperactivity

atypical

automobile accidents

autonomic dysfunction

behavioral disorder

benzodiazepine

bitemporal visual field defect

bromocriptine, slow release

carpal tunnel syndrome

CAT scan

CAT scan, abnormal

CAT scan, chest

catechol-o-methyltransferase inhibitor

cerebellar pontine angle

cerebellar pontine angle tumor

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, leak

cerebrovascular accident, women

chest x-ray, abnormal

Chiari Frommel syndrome

chromophobe adenoma, treatment of

cirrhosis

cisternogram, radionuclide

congestive heart failure

conjunctival injection

constipation

controversies in neurology

coprolalia

coronary artery disease

cost effectiveness

cough

cranial nerve palsies

dexamethasone suppression test

diabetes mellitus

dialysis

diplopia

disability rating scale, neurological

disability, neurological

dopamine agonist withdrawal syndrome

dopamine antagonist

dopamine antagonist, peripheral

dopamine receptor

dopamine receptor, D2

doppler, transcranial

downward gaze, paralysis of

driving

drug induced neurologic disorders

echocardiogram, transthoracic

edema, pedal

efficacy

emergencies, neurologic

eye movement, disorders of

fine motor function, impaired

follicle stimulating hormone

gastrointestinal bleeding

gaze palsy, horizontal

gaze palsy, vertical

gene

gene mutation

Gilles de la Tourette syndrome

glabellar sign

goiter

growth hormone

growth hormone deficiency

guanfacine

hair, loss

hallucination

hallucination, auditory

haloperidol

handwriting

headache

headache, drug induced

headache, prophylaxis

headache, treatment of

hearing loss

hemidystonia

hepatic encephalopathy

hepatic encephalopathy, treatment of

heralding manifestation

hypothalamus, damage to

hypothermia

hypothyroidism

iatrogenic neurologic disorders

internuclear ophthalmoplegia

intracerebral hemorrhage

L-dopa, controlled release

L-dopa, drug interactions with and side effects of

lergotrile

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

medication withdrawal

microsurgery, transsphenoidal

migraine

migraine, menses

migraine, prophylaxis

migraine, treatment of

misdiagnosis

mitral valve lesion

mitral valve regurgitation

monoamine oxidase inhibitors

mortality

movement disorder

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, extrapyramidal-treatment of

movement disorder, treatment of

MRI

MRI, abnormal

MRI, contrast enhanced

narcolepsy

nausea and vomiting

Nelson's syndrome

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS-treatment of

neoplasm, pituitary

neoplasm, pituitary, incidental

neoplasm, pituitary, treatment of

neoplasm, primary of CNS-metastasizing to subarachnoid space

neoplasm, primary of CNS-treatment of

neuroendocrinology

neuroleptic

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications of, surgery

neurologic disease, diagnoses of

neurologic signs

neurologic symptoms

neurologic testing

neuronal degeneration

neuropathology

neuropathology, brain

neuropathy

neuroprotective agents

nonsteroidal anti-inflammatory drug

obsessive-compulsive disorder

optic chiasm, herniation

oral contraceptives

oral contraceptives, neurologic complications with

orthostatic hypotension

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, driving with

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

pathologic gambling

pathology

patient information and support

PHNO, enteral infusion, continuous

pituitary, adenoma, giant

pituitary, enlargement

pituitary, hormones of

pituitary, lesion of

pituitary, microadenoma

polyps, gastrointestinal tract

polysomnogram

postpartum

postpartum cerebral angiopathy

practice guidelines

pramipexole

pramipexole, extended release

pregabalin

pregnancy, neurologic complications in

prognosis

progressive supranuclear palsy

psychiatric problems in neurologic disorders

radiation therapy, CNS treatment and complications with

radiation therapy, stereotactic

radioimmunoassay

respiratory failure

restless arms syndrome

restless genital syndrome

restless leg syndrome

retroperitoneal fibrosis

risk-benefit assessment

ropinirole

ropinirole, prolonged release

rotigotine

safety

seizure

sella turcica, enlargement of

sensorineural hearing loss

serotonin agonist

serum tumor markers

sinemet

single photon emission computed tomography

skin, lesions in neurologic disorders

skull x-ray

skull x-ray, abnormal

sleep

sleep apnea

sleep pathology and physiology

smell

somatostatin analogue

stem cell transplantation

stimulation, deep brain

subclavian steal syndrome, causes of

testosterone, serum, low

thiothixene

tic

tic, classification of

transdermal medication

treatment of neurologic disorder

tremor

tremor, resting

tremor, thalamic stimulation for suppression of

tricuspid valve, lesion of

Unified Parkinson Rating Scale

visual acuity, decreased

Showing articles 300 to 350 of 1085 << Previous Next >>

Treatment with D-penicillamine Improves Dopamine D2-Receptor Binding and T2-Signal Intensity in de novo Wilson's Disease
Neurol 44:1079-1082, Schwarz,J.,et al, 1994

Migraine:A Pharmacologic Review with Newer Options and Delivery Modalities
Neurol 44:S13-S17, Baumel,B., 1994

Reverse Shapiro's Syndrome:Hirayama
K. , et al, Arch Neurol 51:494-49694., , 1994

Is There a Problem with Long Term Use of Sumatriptan in Acute Migraine?
BMJ 308:113, Osborne,M.J.,et al, 1994

Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
NEJM 330:613-622, Lipton,S.A.&Rosenberg,P.A., 1994

Clinical Exper from Sweden on Use of Subcutaneously Admin Sumatriptan in Migraine & Cluster Headache
Arch Neurol 51:1256-1261, Dahlof,C.,et al, 1994

Treatment of Parkinson's Disease
NEJM 329:1021-1027, Calne,D.B., 1993

Postmarketing Study of Cardiovascular Adverse Reactions Associated with Sumatriptan
BMJ 307:1185, Ottervanger,J.P.,et al, 1993

Schizophrenia as a Brain Disease, The Dopamine Receptor Story
Arch Neurol 50:1093-1095, 10971993., Seeman,P., 1993

Multiple System Atrophy & Prog Supranuc Palsy, Dimin Striatal D2 Dopamine Receptor Act by SPECT
Arch Neurol 50:513-516, vanRoyen,E.,et al, 1993

Sumatriptan and Chest Pain
Lancet 341:1564-1565, Hillis,W.S.&MacIntyre,P.D., 1993

Transmural Myocardial Infarction with Sumatriptan
Lancet 341:861-862, Ottervanger,J.P.,et al, 1993

Efficacy of Subcutaneous Sumatriptan in Repeated Episodes of Migraine
Neurol 43:1363-1368, Cady,R.K.,et al, 1993

Sumatriptan
Lancet 341:221-224, Bateman,D.N., 1993

The Prevalence of Metoclopramide-Induced Tardive Dyskinesia and Acute Extrapyramidal Movement Disorders
Arch Int Med 153:1469-1475, Ganzini,L.,et al, 1993

Sumatriptan for Migraine
The Medical Letter, 34:91-931992., , 1992

Dose Ranging Efficacy & Safety of Subcut Sumatriptan in Acute Treat of Migraine
Arch Neurol 49:1271-1276, Mathew,N.T.,et al, 1992

Drug-Induced Movement Disorders:An Overview
In Movement Dis in Neurol & Neuropsych, Blackwell Sci Publ, Boston, 2:21., Miller,L.G.&Jankovic,J., 1992

Extrapyramidal side Effects of Antiemetics Presenting as Psychiatric Illness
Gen Hosp Psychiatry 14:192-195, Rodgers,C., 1992

Striatal D2 Receptor Status in Patients with Parkinson's Disease, Striatonigral Degeneration, and PSP, (PET)
Ann Neurol 31:184-192, Brooks,D.J.,et al, 1992

123I-iodobenzamide-SPECT Predicts Dopaminergic Responsiveness in patients with De Dovo Parkinsonism
Neurol 42:556-561, Schwarz,J.,et al, 1992

Sumatriptan
Serotonin, Migraine, and Money, Editorial, Lancet 339:151-1522., , 1992

Coronary Vasospasm Induced by Subcutaneous Sumatriptan
BMJ 304:1415, Willett,F.,et al, 1992

Emergency Treatment of Headache
Neurol 42 (Suppl 2) :43-44992., Rapoport,A.M.&Silberstein,S.D., 1992

Treatment of Migraine
Lancet 339:1207-1209, Lance,J.W., 1992

Tardive Dyskinesia Associated with Use of Metoclopramide in a Child
J Pediatr 121:983-985, Putnam,P.E.,et al, 1992

Sumatriptan:Efficacy and Contribution to Migraine Mechanisms
JNNP 55:1103-1105, Pearce,J.M.S., 1992

Sumatriptan in Migraine, May be Better than Aspirin and Metoclopramide
BMJ 303:1491, Pearce,J.M.S., 1991

Oral Sumatriptan in Acute Migraine
Lancet 338:782-783, Goadsby,P.J.,et al, 1991

Treatment of Acute Migraine with Subcutaneous Sumatriptan
JAMA 265:2831-2835, Cady,R.K.,et al, 1991

Treatment of Migraine Attacks with Sumatriptan
The Subcutaneous Sumatriptan International Study Group, NEJM 325:316-321, 353-354991., , 1991

Migraine Pain Associated with Middle Cerebral Artery Dilatation:Reversal by Sumatriptan
Lancet 338:13-17, Friberg,L.,et al, 1991

Treatment of Acute Cluster Headache with Sumatriptan
The Sumatriptan Cluster Headache Study Group, NEJM 325:322-326, 353-354991., , 1991

Oculogyric Crisis after Metoclopramide Therapy
Optometry and Vision Science 66:179-180, Edward,M.,et al, 1989

Physiology & Pharmacology of Dopamine D2-Receptors:Their Implications in Dopamine-Substitute Therapy for Park
Neurol 39:1106-1108, Mercuri,N.B.,et al, 1989

Postmortem Analysis of Adrenal-Medulla-to-Caudate Autograft in a Patient with Parkinson's Disease
Ann Neurol 25:607-614, Hurtig,H.,et al, 1989

Drugs Acting on 5-Hydroxytryptamine Receptors
Editorial, Lancet 2:717-7191989., , 1989

Metoclopramide-Induced Movement Disorders
Arch Int Med 149:2486-2492, Miller,L.G.&Jankovic,J., 1989

Acute Upper Airway Obstruction Due to Supraglottic Dystonia Induced by a Neuroleptic
BMJ 297:964-965, Newton-John,H., 1988

Possible Benefit of GR43175, A Novel 5-HT1-Like Receptor Agonist for the Acute Treatment of Severe Migraine
Lancet 1:1309-1311, Doenicke,A.,et al, 1988

Metoclopramide-Induced Neuroleptic Malignant Syndrome
Arch Int Med 147:1495-1497, Friedman,L.S.,et al, 1987

Extrapyramidal Disturbances Caused by Inappropriate Prescribing
BMJ 295:30-31, Pall,H.S.&Williams,A.C., 1987

Dopamine D2 Receptor Density Remains Constant in Treated Parkinson's Disease
Ann Neurol 19:487-492, Guttman,M.,et al, 1986

Metoclopramide-Induced Parkinsonism in Hemodialysis Patients
Arch Int Med 146:2070-2071, Sirota,R.A.,et al, 1986

Tardive Dyskinesia Associated with High-Dose Intravenous Metoclopramide
NEJM 315:518-519, Breitbart,W., 1986

Pimozide for Tourette's Disorder
Medical Letter 27:3-4, , 1985

Extrapyramidal Reactions with Metoclopramide
BMJ 291:930-932, Bateman,D.N.,et al, 1985

Metoclopramide & Tardive Dyskinesia in the Elderly
BMJ 289:397-398, Orme,M.L., 1984

Treatment of Tourette's Syndrome with R022-1913, A D-2-Receptor Antagonist
NEJM 311:989, Uhr,S.B.,et al, 1984

Prolonged Metoclopramide-Induced Dyskinetic Reaction
Neurol 34:238-239, Leopold,N.A., 1984

Showing articles 300 to 350 of 1085 << Previous Next >>